Search for other works by this author on: ...

Search for other works by this author on: ...

Adding the PD-1 inhibitor pembrolizumab to chemoradiotherapy for high-risk, locally advanced cervical cancer significantly improves patients’ overall survival compared to treatment with CRT alone.

University of Nebraska Medical Center, Omaha, NE, ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.

Copyright held by the owner/author(s).

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Two HER2-targeted tyrosine kinase inhibitors, BAY 29270078 and zongertinib, each showed robust efficacy and safety in early phase. Patients experienced significant tumor shrinkage rates, and the ...

According to data presented at the ESMO Congress 2024, being held from September 13–17 in Barcelona, Spain, for patients with advanced renal cell carcinoma, oncologists should avoid prescribing ...

Search for other works by this author on: ...